Your browser doesn't support javascript.
loading
Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial.
Fox, Keith A A; Eikelboom, John W; Shestakovska, Olga; Connolly, Stuart J; Metsarinne, Kaj P; Yusuf, Salim.
Afiliação
  • Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom. Electronic address: k.a.a.fox@ed.ac.uk.
  • Eikelboom JW; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada.
  • Shestakovska O; Population Health Research Institute, Hamilton, Ontario, Canada.
  • Connolly SJ; Population Health Research Institute, Hamilton, Ontario, Canada.
  • Metsarinne KP; Turku University Central Hospital and Turku University, Turku, Finland.
  • Yusuf S; Department of Medicine, McMaster University, Hamilton, Ontario, Canada; Population Health Research Institute, Hamilton, Ontario, Canada.
J Am Coll Cardiol ; 73(18): 2243-2250, 2019 05 14.
Article em En | MEDLINE | ID: mdl-31072566

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Aspirina / Insuficiência Renal Crônica / Doença Arterial Periférica / Rivaroxabana / Hemorragia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Aspirina / Insuficiência Renal Crônica / Doença Arterial Periférica / Rivaroxabana / Hemorragia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article